ConductScience.org, home

Comparison · NCT04790279-531c1452

Amlodipine vs Nifedipine ER: Number of Patients Reporting Satisfaction With Breastfeeding Experience on Patient-completed Questionnaire

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Amlodipine vs Nifedipine ER: Number of Patients Reporting Satisfaction With Breastfeeding Experience on Patient-completed Questionnaire. Trial comparisons, record NCT04790279-531c1452. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04790279-531c1452

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.8150.6330.918wilson
Risk in group 20.8890.7470.956wilson
Risk difference, group 1 minus group 2-0.0741-0.2680.102newcombe hybrid score
Risk ratio, group 1 over group 20.9170.741.14log
Odds ratio, group 1 over group 20.550.1332.28log
Number needed to treat, for one fewer participant with the outcome on Amlodipine than on Nifedipine ER13.5from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1AmlodipineAmlodipine Per Protocol2227OG000
Group 2Nifedipine ERNifedipine ER Per Protocol3236OG001

Outcome

Type
SECONDARY
Title
Number of Patients Reporting Satisfaction With Breastfeeding Experience on Patient-completed Questionnaire
Description
Time frame
until 6 weeks postpartum
Population
Only includes patients who answered relevant question on breastfeeding questionnaire

Source ClinicalTrials.gov

Trial

Title
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
NCT number
NCT04790279
Phases
PHASE4
Conditions
Hypertension in Pregnancy
Interventions
Amlodipine, NIFEdipine ER
Lead sponsor
Prisma Health-Upstate
Results first posted
2024-10-28

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04790279-531c1452